Data di Pubblicazione:
1998
Citazione:
Fludarabine and cytosine-arabinoside for poor-risk acute myeloid leukemia / Russo, D.; Candoni, A.; Grattoni, R.; Bertone, A.; Zaja, F.. - In: HAEMATOLOGICA. - ISSN 0390-6078. - 83:3(1998), pp. 281-288.
Abstract:
Thirteen relapsed or refractory AML patients were treated with the FLA regimen. A complete remission was observed in 54% of cases but the median duration of remission was short (4 months). These results suggest that the FLA regimen is not able to induce a durable complete remission in the poor- risk AML patients.
Tipologia CRIS:
Articolo su rivista
Keywords:
Acute myeloid leukemia; Cytosine-arabinoside; Fludarabine; Treatment
Elenco autori:
Russo, D.; Candoni, A.; Grattoni, R.; Bertone, A.; Zaja, F.
Link alla scheda completa:
Pubblicato in: